Latest filing published 15 Jun 2012 for ISTA PHARMACEUTICALS INC, €211k.
No signal scores available.
Glenn Eugene Davis is a declared insider of Ista Pharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 28 January 2011 and the latest from 6 June 2012.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 15 June 2012 came the latest disclosure, a transaction for €211k in Ista Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations